As we found many changes in miRNA expression across the five clinical tumor subtypes we had defined above (Figure 2), we asked whether DICER1, DROSHA, DGCR8, AGO1, AGO2, AGO3 or AGO4 expression differs among these subgroups. Here, AGO3 is linked to neoplasm.